Recombinant von Willebrand factor and tranexamic acid for heavy menstrual bleeding in patients with mild and moderate von Willebrand disease in the USA (VWDMin): a phase 3, open-label, randomised, crossover trial
Titel:
Recombinant von Willebrand factor and tranexamic acid for heavy menstrual bleeding in patients with mild and moderate von Willebrand disease in the USA (VWDMin): a phase 3, open-label, randomised, crossover trial
Auteur:
Ragni, Margaret V Rothenberger, Scott D Feldman, Robert Nance, Danielle Leavitt, Andrew D Malec, Lynn Kulkarni, Roshni Sidonio Jr, Robert Kraut, Eric Lasky, Joseph Pruthi, Rajiv Angelini, Dana Philipp, Claire Hwang, Nina Wheeler, Allison P Seaman, Craig Machin, Nicoletta Xavier, Frederico Meyer, Michael Bellissimo, Daniel Humphreys, Gregory Smith, Kenneth J Merricks, Elizabeth P Nichols, Timothy C Ivanco, Dana Vehec, Deborah Koerbel, Glory Althouse, Andrew D